Outcome of Hydroxyurea Use in SCD and Evaluation of Patients’ Perception and Experience in Nigeria

Introduction: Hydroxyurea (HU) has been shown to be beneficial in the management of sickle cell disease (SCD) as it improves treatment outcomes. However, despite the benefits of HU, its uptake among SCD patients in Nigeria remains low. Objective: This study aimed to assess the perception and experie...

Descripción completa

Detalles Bibliográficos
Autores principales: Chianumba, Reuben Ikechukwu, Ofakunrin, Akinyemi O. D., Morrice, Jack, Olanrewaju, Olaniyi, Oniyangi, Oluseyi, Kuliya-Gwarzo, Aisha, Nnebe-Agumadu, Uche, Isa, Hezekiah Alkali, Nnodu, Obiageli Eunice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987287/
https://www.ncbi.nlm.nih.gov/pubmed/35401653
http://dx.doi.org/10.3389/fgene.2022.826132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987287/
https://www.ncbi.nlm.nih.gov/pubmed/35401653
http://dx.doi.org/10.3389/fgene.2022.826132

Ejemplares similares